Market Currents
Amylin (AMLN +1%) spiked a little near the close following a report Bristol-Myers (BMY) is still...
-
Thursday, April 5, 2012, 4:33 PM ETAmylin (AMLN +1%) spiked a little near the close following a report Bristol-Myers (BMY) is still eying the drugmaker, which reportedly turned down a $22/share offer earlier this year. Amylin, which is under pressure from Carl Icahn to consider a sale, closed at $24.12.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment:
Bydureons potential - especially as they move to one mos especially when you look at weight loss (one of the few mega block busters left). Icahn may understand finance but he doesn't understand medicine